Kumamoto Tsutomu, Toda Shigeo, Matoba Shuichiro, Moriyama Jin, Hanaoka Yutaka, Tomizawa Kenji, Sawada Toshihito, Kuroyanagi Hiroya
Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Department of Colorectal Surgery, Yokoyama Hospital, Miyazaki, Japan.
World J Surg. 2017 Aug;41(8):2153-2159. doi: 10.1007/s00268-017-3976-9.
The use of laparoscopic surgery for colorectal cancer has become widespread recently. However, the safety and oncological outcomes of laparoscopic surgery for primary advanced colorectal cancer need extensive investigation. We analyzed the short- and long-term outcomes after laparoscopic multivisceral resection for primary colon cancer with suspected invasion of other organs at a single institution.
Between January 2000 and December 2014, 118 patients underwent laparoscopic multivisceral resection for primary colon cancer invading or adhering to adjacent organs or structures; their short- and long-term outcomes were retrospectively evaluated.
The median operating time was 254 min (range 130-1051 min), and median blood loss was 48 ml (range 0-2777 ml). The overall conversion rate was 6.8%. The postoperative complication rate was 17.8%. The number of patients with R0 and R1 resection was 112 (94.9%) and 6 (5.1%), respectively. At a median follow-up period of 32 months (range 0-157 months), the local recurrence rate in patients who underwent R0 resection was 1.8%, while for R1 resection it was 66.7%. In multivariate analysis, R1 resection and LN metastases were found to be predictors of poor prognosis. The cancer-specific 5-year survival was 87% when R0 resection was achieved; within these, the 5-year survival rates for patients with stages II, III, and IV disease were 94, 81, and 40%, respectively.
Laparoscopic en bloc multivisceral resection for clinically suspected T4 colon cancer is a safe and feasible procedure for precisely selected patients, attaining satisfactory oncological outcomes when R0 resection is achieved.
近年来,腹腔镜手术在结直肠癌治疗中的应用日益广泛。然而,腹腔镜手术治疗原发性进展期结直肠癌的安全性和肿瘤学结局仍需深入研究。我们分析了在单一机构中,对疑似侵犯其他器官的原发性结肠癌行腹腔镜多脏器切除术后的短期和长期结局。
2000年1月至2014年12月期间,118例患者因原发性结肠癌侵犯或粘连至邻近器官或结构而接受了腹腔镜多脏器切除术;对其短期和长期结局进行回顾性评估。
中位手术时间为254分钟(范围130 - 1051分钟),中位失血量为48毫升(范围0 - 2777毫升)。总体中转率为6.8%。术后并发症发生率为17.8%。R0切除和R1切除的患者数量分别为112例(94.9%)和6例(5.1%)。中位随访期为32个月(范围0 - 157个月),R0切除患者的局部复发率为1.8%,而R1切除患者的局部复发率为66.7%。多因素分析显示,R1切除和淋巴结转移是预后不良的预测因素。实现R0切除时,癌症特异性5年生存率为87%;其中,II期、III期和IV期疾病患者的5年生存率分别为94%、81%和40%。
对于临床怀疑为T4期的结肠癌,腹腔镜整块多脏器切除术对经过精确筛选的患者而言是一种安全可行的手术方式,实现R0切除时可获得满意的肿瘤学结局。